Mingxin China Growth Fund

investment firm

About

Mingxin China Growth Fund is an international private equity fund, focusing on growth stage companies in China and looking for investment.

Details

Operating Status
Active
Also Known As
Mingly China Growth Fund,名信中国成长基金,Mingxin Zhongguo Chengzhang Jijin
Investor Type
PE

Mingxin China Growth Fund is a venture capital firm specializing in growth and expansion stage investments. The firm typically invests in telecommunication, media, technologies; consumer goods and services; healthcare, pharmaceuticals and biotech; clean tech; advanced manufacturing; agriculture; education; and business and financial services sectors. It seeks to invest in companies based in China. Mingxin China Growth Fund is based in Beijing, China with additional offices in Shanghai, China; Shandong, China; Central, Hong Kong; and Palo Alto, California.

Investments

Number of Investments
Number of Lead Investments
9
1
Mingxin China Growth Fund has made 9 investments. Their most recent investment was on Dec 7, 2019, when Remegen raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 7, 2019 Remegen
Private Equity(PE) Biotechnology
Oct 15, 2015 PegBio
Series C ¥7M Health Care
Feb 12, 2014 Oorja Fuel Cells
Series E $3.45M Energy Yes
Jul 25, 2013 Percent
Series B $10M Analytics
Jul 25, 2011 Percent
Series A $7.20M Analytics

Employee Profiles

Number of Employee Profiles
1
Mingxin China Growth Fund has 1 current employee profiles, including Employee Jim Boettcher
Employee

Exits

Mingxin China Growth Fund has had 1 exits. Mingxin China Growth Fund most notable exits include Remegen

Date Company Name Exit Type Industry
Apr 1, 2022 Remegen IPO Biotechnology Detail